Major changes in China’s pharmaceutical market 2018

A review on imminent changes includes: 1. A „two vote“ system for instruments and consumables, 2. Policy support for home-made instruments, 3. Outpatient services will be improved, 4. County-level hospitals will be upgraded, 5. Genetic screening will be reformed 14...

China has launched the „Pig Model Project“ (PMP)

Following an International Forum on Animal Biotechnology, the Chinese Academy of Engineering has announced that the country will launch the international pig model project (PMP, http://www.pigmodel.org). Organized by the Ministry of Science 
and Technology and...

CAS QIBEBT promotes duckweed as a bioremediation plant

The group of ZHOU Gongke at QIBEBT has used molecular biology, cell biology and bioinformatics and other research methods to elucidate the molecular biology of cadmium ion absorption, transport and detoxification in duckweed. The advantage of duckweed bioremediation...

BGI’s share value exceeds 100 billion Yuan

As a leading enterprise in China’s genetic testing industry, BGI combines strong R & D self-developed instruments and reagents to effectively control costs. The rapid growth of the reproductive and health businesses has formed a scale effect and BGI is active in...